Literature DB >> 2300999

The influence of preservation injury on rejection in the hepatic transplant recipient.

T K Howard1, G B Klintmalm, J B Cofer, B S Husberg, R M Goldstein, T A Gonwa.   

Abstract

The records of 215 liver transplant recipients were reviewed and the degree of preservation injury was estimated by the initial aminotransferase levels. This was compared with the incidence of rejection found in the subsequent 30 days. Those with aspartate aminotransferase greater than 2000 U/L were classified as having severe preservation injury while those with ASAT less than 600 U/L were considered to have had minimal preservation injury. There were no significant differences between these groups in recipient age, sex, cold ischemia time, preoperative physical status, panel-reactive antibodies, or cytotoxic crossmatch. The solution used for organ preservation and the donor age were the only factors that were found to be significantly different between the groups. Older donors were more common in the severe preservation injury group. Severe preservation injury was found more frequently in grafts preserved in Eurocollins solution and the group with minimal preservation injury more frequently used Wisconsin solution. There was significantly more rejection seen in the severe preservation injury group (71%) than in the group without preservation injury (33%). Although there was more rejection in the severe preservation injury group, the rejections were not more severe as judged by the need for multiple courses of therapy or the need for OKT3. Recurrent rejection was also not more frequent in either group. Graft survival was worse in the severe preservation injury group, with a significant increase in early graft loss, but no difference in the frequency of chronic rejection. Recovery of graft function was also delayed in the preservation injury group.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2300999     DOI: 10.1097/00007890-199001000-00023

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  42 in total

1.  Prevention of neutrophil migration ameliorates rat lung allograft rejection.

Authors:  Shin Hirayama; Takeshi Shiraishi; Takayuki Shirakusa; Takao Higuchi; Edmund J Miller
Journal:  Mol Med       Date:  2006 Sep-Oct       Impact factor: 6.354

2.  Reperfusion injury following cold ischemia activates rat liver Kupffer cells.

Authors:  P N Rao; T Liu; J T Synder; J L Platt; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

3.  Indocyanine green elimination test in orthotopic liver recipients.

Authors:  T Tsubono; S Todo; N Jabbour; A Mizoe; V Warty; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1996-11       Impact factor: 17.425

Review 4.  Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation.

Authors:  Y Zhai; R W Busuttil; J W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2011-06-10       Impact factor: 8.086

5.  Cell-cell and cell-matrix adhesion molecules in human heart and lung transplants.

Authors:  G Steinhoff; A Haverich
Journal:  Mol Cell Biochem       Date:  1995 Jun 7-21       Impact factor: 3.396

6.  Effect of matrine on Kupffer cell activation in cold ischemia reperfusion injury of rat liver.

Authors:  Xin-Hua Zhu; Yu-Dong Qiu; Hao Shen; Ming-Ke Shi; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

7.  Results of split liver transplantation in children.

Authors:  Rahul R Deshpande; Matthew J Bowles; Hector Vilca-Melendez; Parthi Srinivasan; Raffaele Girlanda; Anil Dhawan; Giorgina Mieli-Vergani; Paolo Muiesan; Nigel D Heaton; Mohamed Rela
Journal:  Ann Surg       Date:  2002-08       Impact factor: 12.969

Review 8.  In situ splitting of cadaveric livers. The ultimate expansion of a limited donor pool.

Authors:  X Rogiers; M Malagó; K Gawad; K W Jauch; M Olausson; W T Knoefel; M Gundlach; A Bassas; L Fischer; M Sterneck; M Burdelski; C E Broelsch
Journal:  Ann Surg       Date:  1996-09       Impact factor: 12.969

9.  Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury.

Authors:  Takashi Hamada; Seiichiro Tsuchihashi; Armine Avanesyan; Sergio Duarte; Carolina Moore; Ronald W Busuttil; Ana J Coito
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

10.  Inducible nitric oxide synthase deficiency impairs matrix metalloproteinase-9 activity and disrupts leukocyte migration in hepatic ischemia/reperfusion injury.

Authors:  Takashi Hamada; Sergio Duarte; Seiichiro Tsuchihashi; Ronald W Busuttil; Ana J Coito
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.